ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3,2,Miliaria,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5,1,Hereditary angioedema,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
6,1,Hereditary angioedema,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
7,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
9,1,Cluster headache,Headaches NEC,Headaches,Nerv,N
9,2,Hereditary angioedema,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
10,1,Apparent death,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11,2,Hereditary angioedema,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
12,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
13,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
13,2,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
14,1,Hereditary angioedema,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
14,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
14,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
15,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
16,1,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
16,2,Hereditary angioedema,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
16,3,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
16,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
17,1,Hereditary angioedema,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
17,2,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
18,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
19,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
19,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
20,1,Headache,Headaches NEC,Headaches,Nerv,N
20,2,Hereditary angioedema,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
20,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
20,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
21,1,Hereditary angioedema,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
21,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
22,1,Hereditary angioedema,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
22,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
23,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
24,1,Hereditary angioedema,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
24,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
25,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
25,2,Hereditary angioedema,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
26,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
26,2,Hereditary angioedema,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
26,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
27,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
28,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
28,2,Hereditary angioedema,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
28,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
29,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
29,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
30,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
30,2,Hereditary angioedema,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
30,3,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
31,1,Hereditary angioedema,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
32,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
33,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
33,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
33,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
34,1,Hereditary angioedema,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
35,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
35,2,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
36,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
36,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
37,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
37,2,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
38,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
39,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
40,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
40,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
41,1,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
42,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
43,1,Hereditary angioedema,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
43,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
44,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
44,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
45,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
46,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
47,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
48,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
48,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
48,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
48,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
49,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
49,2,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
50,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
50,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
51,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
51,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
52,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
52,2,Headache,Headaches NEC,Headaches,Nerv,N
52,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
52,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
52,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
52,6,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
52,7,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
